An exciting new therapy for people with blood cancer has been approved for use in the USA. It involves collecting a patient’s own immune cells, modifying them to target cancer cells more efficiently and then injecting them back into the patient. The treatment, called Kymriah and produced by drug company Novartis, is one of many…
James Robinson, Senior Bioinfomatics Scientist at the Anthony Nolan Research Institute, is part of the team that runs the HLA database – keeping track of the thousands of genetic variations that we come across when typing donors and patients.
Here, he tells us why that work is important and explains his latest research findings.
After Ronnie Manders was born with a rare form of childhood leukaemia, his family began rallying – both to add more donors to the Anthony Nolan register, and to raise lifesaving money in support of our research. This is the story of an amazing family – Ronnie’s family.
Exciting news from the world of research – a new test has been developed which uses biomarkers to help identify which patients have a higher risk of developing complications post-transplant.
In today’s blog, we give you the facts.
Illnesses and diseases have been with humans since the dawn of time. But sometimes – with good medicine, and research – we’ve been able to prevent illnesses from spreading too far or affecting too many lives. Find out more in our handy graphic:
Today we’re looking at the etymology behind a wide variety of well-known diseases – in many cases, based on the scientists and researchers who worked tirelessly to discover and document them.